<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1604">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02064400</url>
  </required_header>
  <id_info>
    <org_study_id>NUTH6919</org_study_id>
    <nct_id>NCT02064400</nct_id>
  </id_info>
  <brief_title>Pilot Study of Ultrasound in Rheumatoid Arthritis</brief_title>
  <official_title>A Pilot Study of Musculoskeletal Ultrasound Assessment in Patients With Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Newcastle-upon-Tyne Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Newcastle University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wellcome Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Newcastle-upon-Tyne Hospitals NHS Trust</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Little is currently known as to the predictive value of ultrasound in guiding the decision
      to taper drug treatment in patients with stable rheumatoid arthritis, nor the influence that
      patients' views and opinions regarding their medications may have upon this. In this study,
      patients with stable rheumatoid arthritis will undergo a simple examination of their joints
      to look for any swelling or tenderness followed by an ultrasound scan to look for joint
      inflammation. Half of the patients will also complete an interview to assess their views and
      opinions of arthritis drug treatment. The study will be completed in a single patient visit
      - no invasive tests will be performed, and no changes to treatment will be made.

      This study is being conducted as part of a Masters degree from Newcastle University. The
      results of this study will be used to inform the feasibility of inclusion of ultrasound
      assessment within the design of a future PhD study to investigate potential markers of
      remission in patients with rheumatoid arthritis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Evidence of reliability of intra- and inter-rater ultrasound agreement for power Doppler synovitis score</measure>
    <time_frame>At recruitment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Defined as Kappa statistic of at least 0.4.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Qualitative data relating to patients' views and opinions of their arthritis medication</measure>
    <time_frame>At recruitment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Based upon data collected by a semi-structured interview approach and analysed using standard qualitative techniques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simplified Disease Activity Index (SDAI)</measure>
    <time_frame>At recruitment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease Activity Score in 28 joints (DAS-28)</measure>
    <time_frame>At recruitment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease Activity Score (DAS)</measure>
    <time_frame>At recruitment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Observational study group</arm_group_label>
    <description>Musculoskeletal ultrasound (all patients) and semi-structured patient interview (anticipated maximum 15 patients)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Musculoskeletal Ultrasound</intervention_name>
    <description>7-joint musculoskeletal ultrasound scan</description>
    <arm_group_label>Observational study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Semi-structured patient interview</intervention_name>
    <description>Semi-structured patient interview</description>
    <arm_group_label>Observational study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Secondary care rheumatology outpatient clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of rheumatoid arthritis with symptom onset at least 12 months previously

          -  Current disease-modifying anti-rheumatic drug (DMARD) therapy or biologic therapy

          -  Currently stable arthritis defined as no change in DMARD treatment over previous 6
             months, and no use of steroids (enteral, parenteral or intra-articular) over previous
             6 months

        Exclusion Criteria:

          -  Inability to provide informed consent

          -  Current or recent (within 4 months) participation within another clinical trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John D Isaacs, PhD, MB BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Newcastle University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John D Isaacs, PhD, MB BS</last_name>
    <phone>+44191 222 5337</phone>
    <email>john.isaacs@ncl.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kenneth F Baker, BA, BM BCh</last_name>
    <phone>+44191 222 5337</phone>
    <email>k.f.baker@ncl.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Musculoskeletal Outpatient Department, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John D Isaacs, PhD, MB BS</last_name>
      <phone>+44191 222 5337</phone>
      <email>john.isaacs@ncl.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Kenneth F Baker, BA, BM BCh</last_name>
      <phone>+44191 222 5337</phone>
      <email>k.f.baker@ncl.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>John D Isaacs, PhD, MB BS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 8, 2014</lastchanged_date>
  <firstreceived_date>February 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rheumatoid arthritis</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Remission</keyword>
  <keyword>Qualitative</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
